Compared with IgG controls, CCL17 antibody-treated mice exhibited remarkable attenuation of the Ang II–induced cardiac dysfunction, increases in the myocyte area, and myocardial fibrosis (Fig. 5, C–F). This evidence concerns the gene AGT and Myocardial fibrosis.